Eledon Pharmaceuticals, Inc. (ELDN) Tops Q1 EPS by 17c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.08), $0.17 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Micron Technology (MU) call put ratio 1.3 calls to 1 put as share price down 1%